𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lasers in digestive tumours: Factors affecting the results

✍ Scribed by J. M. Brunetaud; V. Maunoury; D. Cochelard; B. Boniface; A. Cortot; J. C. Paris

Book ID
105441118
Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
43 KB
Volume
5
Category
Article
ISSN
0268-8921

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Parameters affecting laser palliation in
Parameters affecting laser palliation in patients with advanced digestive cancers
✍ Professeur Jean Marc Brunetaud; Vincent Maunoury; Dominique Cochelard; Brigitte πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 454 KB

Ninety-nine nonsurgical patients (group I) with esophagogastric cancer were referred to the laser center for palliation of dysphagia, and another 142 nonsurgical patients (group 11) with a rectosigmoid cancer were referred for palliation of abnormal rectal discharge (125 patients) or occlusion (17 p

European disparities in malignant digest
European disparities in malignant digestive endocrine tumours survival
✍ C. Lepage; L. Ciccolallo; R. De Angelis; A.M. Bouvier; J. Faivre; G. Gatta; The πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 281 KB

## Abstract The aim of this study was to report on malignant digestive endocrine tumours (MDET) prognosis in several European countries. We analysed survival data from 19 cancer registries in 12 European countries on 3,715 MDET diagnosed between 1985 and 1994. The overall 5‐year survival rate was 4

T3b-T4breast cancer: factors affecting r
T3b-T4breast cancer: factors affecting results in combined modality treatments
✍ P. Valagussa; M. Zambetti; P. Bignami; M. Lena; M. Varini; R. Zucali; D. Rovini; πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 674 KB

Two hundred and seventy-seven consecutive patients with T3b-T4 breast cancer referred to the Milan Cancer Institute between 1973 and 1980 were treated with a combined modality approach. Chemotherapy (CT) consisted of AV, i.e. adriamycin (60-75 mg/m2 day 1) and vincristine (1.2 mg/m2 days 1 and 8) an